AlmenaFreeMDCCRP

Internal Medicine • Anniston, AL

Hospital Medicine/Hospitalist

Vice President of Medical Affairs/Chief Medical Officer, Regional Medical Center and Stringfellow Hospital Medical Director and principal investigator Pinnacle Research Group Medical director Self Recovery detox

Join to view full profile

Dr. Free is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Free's full profile

Already have an account?

Office
400 E Tenth St
301 E 19th St
Anniston, AL 36207
Phone+1 256-235-5959

Education & Training

Cleveland Clinic FoundationResidency, Internal Medicine, 1993 - 1996
Morehouse School of MedicineClass of 1993

Certifications & Licensure

AL State Medical License 1996 - 2024
OH State Medical License 1995 - 1996

Clinical Trials

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) Start of enrollment: 2008 Feb 01
Completed
Phase 2
Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets Start of enrollment: 2015 Sep 01
Completed
Phase 1
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM Start of enrollment: 2015 Oct 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

6 citations
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Adrienne E Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas
Open Forum Infectious Diseases. 2023-08-01
25 citations
Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin.
Almena Free, Eli Roth, Marybeth Dalessandro, Joe Hirman, Nicole Scangarella
Skinmed. 2006-09-01

Press Mentions

Family, Colleagues Dedicate Heart Lab at RMC in Memory of DoctorJuly 11th, 2023